Correction: Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D3 receptor agonists
Abstract
Correction for 'Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D3 receptor agonists' by Yongkai Cao et al., Med. Chem. Commun., 2018, DOI: 10.1039/c8md00237a.